Show simple item record

dc.contributor.authorJefferson, Tom
dc.contributor.authorDoshi, Peter
dc.contributor.authorThompson, Matthew J.
dc.contributor.authorHeneghan, Carl
dc.date.accessioned2017-05-25T01:20:48Z
dc.date.available2017-05-25T01:20:48Z
dc.date.issued2011-01-11
dc.identifier.citationJefferson, T., Doshi, P., Thompson, M., Heneghan, C. (2011). Ensuring safe and effective drugs: who can do what it takes? BMJ, 342. DOI: 10.1136/bmj.c7258
dc.identifier.urihttp://hdl.handle.net/10713/6616
dc.descriptionDrawing on their experience in producing a Cochrane review of neuraminidase inhibitors for influenza, the authors discuss how to improve the reliability of systematic reviews
dc.description.urihttp://bmj.com/cgi/content/full/bmj.c7258?ijkey=VzuzLond9mt0ghC&keytype=refen_US
dc.language.isoen_USen_US
dc.publisherBMJ Publishing Groupen_US
dc.subjectclinical study reportsen_US
dc.subjectneuraminidase inhibitorsen_US
dc.subjectresearch transparencyen_US
dc.subject.lcshF. Hoffman-La Roche & Co.en_US
dc.subject.lcshCochrane Collaborationen_US
dc.subject.meshAccess to Information--legislation & jurisprudenceen_US
dc.subject.meshClinical Trials as Topicen_US
dc.subject.meshDrug Industryen_US
dc.subject.meshOseltamiviren_US
dc.subject.meshReview Literature as Topicen_US
dc.titleEnsuring safe and effective drugs: who can do what it takes?en_US
dc.typeArticleen_US
dc.identifier.doi10.1136/bmj.c7258
dc.identifier.pmid21224325
dc.description.urinameClick here for the free full-text article on publisher's websiteen_US
refterms.dateFOA2019-02-19T18:16:05Z


Files in this item

Thumbnail
Name:
Doshi_EnsuringSafeEffectiveDru ...
Size:
280.1Kb
Format:
PDF

This item appears in the following Collection(s)

Show simple item record